Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000947871-25-000661
Filing Date
2025-07-11
Accepted
2025-07-11 12:15:48
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 11593
2 JOINT FILING AGREEMENT ss5061645_ex9901.htm EX-99.1 9334
  Complete submission text file 0000947871-25-000661.txt   22807
Mailing Address C/O ATTESTOR VALUE FUND GP LIMITED UGLAND HOUSE, PO BOX 309 GRAND CAYMAN E9 KY1-1104
Business Address C/O ATTESTOR VALUE FUND GP LIMITED UGLAND HOUSE, PO BOX 309 GRAND CAYMAN E9 KY1-1104 44-207-074-9610
Attestor Value Master Fund, LP (Filed by) CIK: 0001627400 (see all company filings)

EIN.: 981053596 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 3030 ROCKY POINT DRIVE SUITE 420 TAMPA FL 33607
Business Address 3030 ROCKY POINT DRIVE SUITE 420 TAMPA FL 33607 701-353-5425
UPEXI, INC. (Subject) CIK: 0001775194 (see all company filings)

EIN.: 833378978 | State of Incorp.: NV | Fiscal Year End: 0630
Type: SCHEDULE 13G | Act: 34 | File No.: 005-93404 | Film No.: 251118151
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)